Objectives: The objective of this study was to perform a multinational survey of patients' colonization by metallo-b-lactamase (MBL)-producing Enterobacteriaceae, including their molecular characterization.
Introduction
Carbapenemase-producing Enterobacteriaceae (CPE) are currently the critical problem in the management of infections. 1, 2 CPE express diverse carbapenem-hydrolysing enzymes, namely metallo-b-lactamases (MBLs), KPCs and OXA-48 types. Apart from carbapenems, MBLs hydrolyse most other b-lactams, including expanded-spectrum cephalosporins (ESCs), and their main types in enterobacteria are VIM-like, IMP-like and NDM-like enzymes.
1,2 VIM-producing Enterobacteriaceae have been observed since 2001 in Greece, 3, 4 and for a decade they prevailed among CPE in Europe; this situation is currently changing due to KPC, OXA-48 and NDM producers. 1, 2, 5 Greece has been most affected by VIM CPE, with the country-wide outbreak peaking in 2006-08. 6 Countries with a noticeable incidence of VIM CPE include Spain, Italy and Poland, whereas France, Sweden and Norway have recorded mainly imports from Greece. 5 Of several VIM subgroups, Enterobacteriaceae usually harbour VIM-1-related enzymes, encoded by gene cassettes of class 1 integrons, 1, 5 such as In-e541-like elements in Greece, 3 In110 and In113 in Spain 7 or In416 in Italy. 8 The integrons are located in diverse plasmids, often in conjugative IncN, IncA/C or IncHI2 types. The EU-funded project MOSAR was a prospective study addressing various aspects of the spread of resistance in hospitals and assessing the effectiveness of specific interventions. 12 Patients in ICUs and rehabilitation units (RUs) were screened for selected pathogens, including ESC-resistant Enterobacteriaceae producing ESBLs, AmpC cephalosporinases, MBLs or/and KPCs (and therefore not OXA-48 alone). This report focuses on MBL CPE and specifically VIM producers.
Methods

Study design, bacterial isolates and b-lactamase identification
Thirteen ICUs and five RUs located in nine countries participated in this study (Table 1) . From mid-2008 until mid-2011, rectal swabs were collected from all patients (n¼17945) at admission and then regularly during their hospital stay and at discharge. The swabs were plated onto Brilliance TM ESBL Agar (Oxoid, Basingstoke, UK); Enterobacteriaceae colonies were identified using the manufacturer's instructions. The species were identified using Vitek 2 (bioMé rieux, Marcy-l'É toile, France). All isolates were tested for ESBL and AmpC expression using the ESBL doubledisc synergy test (DDST) in the absence and presence of cloxacillin (250 mg/L), 13 and for susceptibility to ertapenem, imipenem and meropenem according to EUCAST (http://eucast.org). Isolates that were nonsusceptible to at least one carbapenem were subjected to MBL, KPC and OXA-48 detection, using DDST with EDTA, 14 the phenylboronic acid disc test 15 and the temocillin disc, 16 respectively. All non-duplicate EDTA DDST-positive organisms were screened by PCR for bla VIM -like, bla IMP -like and bla NDM -like MBL genes 17 -19 and for bla KPC genes. 20 Isolates with highlevel temocillin resistance were checked for bla OXA-48 -like genes. 21 MBL producers were retested for ESBLs by DDST with aztreonam discs, followed by PCR for bla CTX-M -type, bla SHV -type and bla TEM -type genes 22, 23 and for bla CMY-2 -like ampC genes. 24 bla VIM s were sequenced within their integrons (see below); other b-lactamase genes were sequenced as previously reported. 20, 22, 24 Typing All MBL-producing isolates were typed by PFGE, using the XbaI enzyme (Fermentas, Vilnius, Lithuania), 25 except for Proteus mirabilis, which was 
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typed using NotI and SfiI (Fermentas). 24 PFGE patterns were analysed visually according to Tenover et al. 26 Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca and Klebsiella pneumoniae were also studied by MLST, 27 -31 using representatives of each pulsotype. The databases at http://pubmlst.org/cfreundii/, http://pubmlst.org/ecloacae, http:// mlst.warwick.ac.uk/mlst/dbs/Ecoli, http://pubmlst.org/koxytoca and http:// bigsdb.web.pasteur.fr/klebsiella, respectively, were used for assigning STs.
Integron analysis
Variable regions of class 1 integrons with bla VIM-1 -like genes were amplified in two parts, from the 5 ′ conserved segment (5 ′ CS) to bla VIM , and from bla VIM to the 3 ′ conserved segment (3 ′ CS). 17 For integrons lacking 3 ′ CS, 3 ′ -parts of the regions were amplified using reverse primers for elements IS26 (In-e541 derivatives with IS1-DIS26 insertions) 32 or ISPa21 (In416-like integrons). 8 Whole-gene arrays were sequenced for 27 isolates, representing different centres, species and pulsotypes/STs. For all other Greek isolates with In-e541-type elements, bla VIM amplicons 17 were cut with HpaII and PagI (Fermentas) to distinguish between bla VIM-1 , bla VIM-26 and bla VIM-39 . HpaII differentiates bla VIM-39 from bla VIM-1/-26 , whereas PagI distinguishes bla VIM-1 from bla VIM-26/-39 . The structures of non-sequenced integrons were confirmed by PCR mapping.
Plasmid analysis
The plasmid profiles of all the isolates were revealed using the nuclease S1 (New England Biolabs, Beverly, MA, USA) assay. 33 The identification of VIM-encoding plasmids was carried out by the hybridization of 27 selected S1 profiles (the same isolates as above) with a bla VIM-1 probe, using the PCR DIG Probe Synthesis and DIG Nucleic Acid Detection kits (Roche Diagnostics, Mannheim, Germany). The same isolates were used in mating with E. coli A15 Rif R22 ; transconjugants were selected with 150 mg/L rifampicin and 50 mg/L ampicillin or 1 mg/L ceftazidime. Plasmid DNA of non-mating isolates, purified using the QIAGEN Plasmid Midi Kit (QIAGEN, Hilden, Germany), was electroporated into E. coli DH5a; transformants were selected using 50 mg/L ampicillin or 1 mg/L ceftazidime. Plasmids of all E. coli recombinants were subjected to S1 profiling and bla VIM-1 hybridization, followed by purification and PCR-based replicon typing. 34, 35 IncR-type replicons were detected as previously described. 36 Nucleotide sequence accession numbers 
Results
Occurrence of MBL-producing Enterobacteriaceae
Patients colonized by MBL CPE were identified in seven ICUs, located in France (RP, Garches; SJ, Paris), Greece (AT and LA, Athens), Italy (CA, Rome), Latvia (RI, Riga) and Portugal (VR, Vila Real), and in two RUs, in Italy (FS, Rome) and Spain (GI, Barcelona) (Table 1) . Altogether, 91 patients were carriers of MBL CPE; six patients had both MBL and KPC CPE, including four patients colonized with organisms co-producing MBL and KPC. Sixty-two patients (68.1%) were in the Greek ICUs, mostly in LA, where 52 MBL CPE carriers constituted 9.3% of all the patients screened. Considering three patients colonized by two different MBL producers (Table 1) , the number of non-duplicate isolates was 94. MBL CPE belonged to nine species (Table 2) , among which K. pneumoniae prevailed (n ¼ 65; 69.1%) due to its predominance in Greece (n ¼ 57; 89.1%). All but one of the isolates expressed VIM-1 types; the exception was an IMP-producing K. pneumoniae from Portugal (VR), which was analysed separately (C. Clonal structure of the MBL CPE K. pneumoniae isolates comprised nine STs, with seven STs identified in Greece (Table 2 ). ST147 prevailed (n¼ 30) and was spread in both Greek ICUs (like ST383), while ST36 (n ¼ 13) was observed only in LA. Isolates from Spain (GI) and France (SJ) belonged to other clones, ST252 and ST1067, respectively, the latter being closely related to the global ST101. 37, 38 Nine E. cloacae isolates represented multiple STs in Greece (LA), Italy (FS) and Latvia (RI); STs of six isolates have previously been shown. 39 Similarly, all five E. coli isolates from Italy (FS) and France (RP) were of different STs, including the pandemic ST410. 19, 40, 41 The recent C. freundii and K. oxytoca MLST schemes have not yet been widely used, 30, 31, 42 so all isolates of these species from Greece (AT), Latvia (RI) and Spain (GI) were classified into new STs.
bla VIM genes and integrons
Five bla VIM -type genes were identified, encoding VIM-1, VIM-12, VIM-19, VIM-26 and VIM-39 ( Table 2 ). All these were found in Greek isolates, whereas strains from other countries had only VIM-1. VIM-39 is a new variant, differing from VIM-1 by two amino acid substitutions, Thr35Ala and His201Leu. The bla VIM -like genes were located in seven major types of class 1 integron, four of which were found mainly in isolates from Greece (Tables 2 and 3 ). The most prevalent were In-e541-like integrons, identified in 53 (56.4%) highly diverse isolates; however, the 'canonical' In-e541 with the intact bla VIM-1 -aacA7-dfrA1-aadA1 gene cassette array 3 occurred only in C. freundii ST18 from AT. The most common (n ¼ 26) were In-e541 derivatives with the aadA1 cassette truncated by 82 bp at the 5 ′ -end (DaadA1), 10, 43 of which those with bla VIM-26 and bla VIM-39 genes (In-e541-like 4 and 5) have been first identified in this work. Another major type, found in various Greek isolates, contained new integrons In4873 with bla VIM-1 and In4863 with bla VIM-19 , differing from the bla VIM-4 -carrying In416 8 only by bla VIM sequences. Among the isolates from other countries, the prevailing integron was In916, 44 identified in diverse organisms (n¼16) from France (SJ), Italy (CA and FS) and Spain (GI). K. oxytoca ST137 from Spain (GI) carried a new integron In3103, differing from In70 45 by having dhfrII instead of aphA15. All the isolates from Latvia (RI) had In110. 7, 46 bla VIM -carrying plasmids A high diversity of plasmid profiles was revealed; even isolates of the same ST/pulsotype varied in S1 profile (Table 2) . Remarkable differences were also seen in bla VIM -carrying plasmids in selected isolates, 20 of which produced E. coli recombinants, allowing for a detailed analysis. The In-e541-like integrons were on molecules with replicons R or FII K , double replicons R+FII K or R+A/C, non-typeable plasmids or presumably in chromosomes ( 
CC, clonal complex; CG, clonal group; ND, not determined; NA, not applicable; NT, non-typeable. a New STs are indicated in bold. b S1 plasmid profiles are numbered within species groups of isolates; profiles differed from each other by the number and/or size of the plasmids. c Plasmids found in transconjugants are shown in bold; plasmids observed in transformants are underlined. d Asterisks indicate the bla VIM genes and integrons that were not sequenced, and their identification was based first on the comparative integron MboI PCR-RFLP analysis; bla VIM-1 , bla VIM-26 and bla VIM-39 genes in Greek isolates were confirmed by the bla VIM HpaII/PagI PCR-RFLP; gene array compositions in all non-sequenced integrons were also confirmed by PCR mapping. e Other b-lactamases found in VIM-producing transconjugants or transformants are in bold or underlined, respectively. f chr, most probably a chromosomal location of a bla VIM -carrying integron, as suggested by the S1 plasmid profiling and bla VIM hybridization. g One profile of this isolate was not determined due to repeated degradation of its plasmid DNA. h This plasmid was co-transferred with a non-typeable plasmid of 200 kb, which might have mobilized the R type to transfer. i Two enzymes shown were co-expressed by all the isolates of this group. j STs of E. cloacae isolates from LA and FS, and one isolate from RI, have previously been reported.
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k Replicon types of bla VIM plasmids in these isolates were not determined because neither transconjugants nor transformants were obtained. l All isolates in this group produced SHV-5 and one isolate additionally had CMY-16. m Three isolates in this group produced only KPC-2, whereas one isolate had only SHV-5.
were 50 kb in size and were non-conjugative, 47 -49 while the other types varied in size and were self-transferable. The remaining bla VIM integrons of Greek isolates were present on IncA/C (In4873), IncHI2 (In87 50 ) or non-typeable plasmids (In4863, In-h12 51 ). Integron In916 was associated with IncA/C ( 150 kb) or IncFII K ( 110 kb) plasmids in Italy, and IncHI2 ( 330 kb) or non-typeable ( 80 kb) molecules in Spain, many of which were transmissible. In110 in the Latvian isolates was located on plasmids of 330 kb that were not transferrable using any approach.
Other b-lactamases
Most of the VIM CPE also expressed ESBLs, acquired AmpCs or KPCs in combinations that were either characteristic for STs/ pulsotypes or varied within these ( Table 2) .
Discussion
Due to reports from individual countries, the knowledge acquired on MBL CPE in Europe has been remarkable; 1,2,5 however, the current study was the first known large-scale multinational survey in which ICU and RU patients were screened within the same time frame and using the same methodology. Therefore, it provides fully comparable data on the proportions of MBL CPE carriage between the clinical sites, although because of it being a convenience sample these cannot be claimed to be representative for such units around Europe. This study confirmed a number of earlier observations on the occurrence of MBL CPE in particular countries and their molecular characteristics, often concerning isolates from Greece or of Greek origin. 1,5,10,11,24,32,48,51 -57 However, this study has also revealed new and valuable data.
Isolates from the ICUs at AT and LA provided a comprehensive view of the progressing evolution of In-e541-like integrons in Greece, generating new bla VIM sequences and gene array variants. Especially of note was the high prevalence and diversification of the variants with the deletion DaadA1 that have so far been reported elsewhere upon importation. 10, 43 The data on the 60 has reinforced the hypothesis of their co-evolution with the DaadA1 In-e541-like elements, based on the similarity of their gene arrays. 8, 59 The most interesting findings referred to In916, which was reported in 2014 in a single E. coli isolate from Spain 44 and in C. freundii in China (GenBank No. KJ547703), and was found here on at least four plasmid platforms among multiple organisms in Spain, France and Italy. It differs in terms of the aphA15 cassette instead of dhfrII from In113, previously described in Spain. 7, 61 On the other hand, the new integron In3103 in K. oxytoca from Spain (GI) differs from In70 in the opposite direction, having dhfrII instead of aphA15. 45 Although In70 has been identified in nonfermenters, 45, 62 it might be that In916 and In3103 arose from cassette shuffling between In113-like and In70-like elements. 1 Yet another striking observation concerned the first MBL CPE ever reported in Latvia, which had In110, the element previously encountered only in Italy and Spain. 7, 46 The data presented here contribute significantly to the current knowledge on VIM CPE in Europe.
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